0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Editorial  | 
Potential Hazards of Adding Nonsteroidal Anti-inflammatory Drugs to Antithrombotic Therapy After Myocardial Infarction:  Time for More Than a Gut Check
Charles L. Campbell, MD; David J. Moliterno, MD
JAMA
Original Investigation  | 
Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial Infarction
Anne-Marie Schjerning Olsen, MD, PhD; Gunnar H. Gislason, MD, PhD; Patricia McGettigan, MD; et al.
JAMA
Original Investigation  | 
Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
Joji B. Kuramatsu, MD; Stefan T. Gerner, MD; Peter D. Schellinger, MD; et al.
JAMA
Original Investigation  | 
Association Between the Use of Fondaparinux vs Low-Molecular-Weight Heparin and Clinical Outcomes in Patients With Non–ST-Segment Elevation Myocardial Infarction
Karolina Szummer, MD, PhD; Jonas Oldgren, MD, PhD; Lars Lindhagen, PhD; et al.